Clinical Research Directory
Browse clinical research sites, groups, and studies.
a Neo-adjuvant Chemotherapy Immunotherapy in Resectable ESCC Study
Sponsor: Zhejiang University
Summary
Research Purpose 1: To evaluate the therapeutic efficacy and safety of neoadjuvant immunotherapy combined with chemotherapy in the treatment of resectable locally advanced esophageal squamous cell carcinoma (ESCC) in the real-world setting. Research Purpose 2: To analyze the influencing factors of the therapeutic effect of neoadjuvant immunotherapy combined with chemotherapy in the treatment of resectable locally advanced esophageal squamous cell carcinoma (ESCC) in the real-world setting. Research Purpose 3: To understand the treatment patterns of neoadjuvant immunotherapy combined with chemotherapy in the treatment of resectable locally advanced ESCC in the
Official title: A Retrospective, Multicenter, Single-arm Real-world Study on a New Adjuvant Chemotherapy Combined With Immune Inhibitors for Resectable Esophageal Squamous Cell Carcinoma (ESCC)
Key Details
Gender
All
Age Range
18 Years - 90 Years
Study Type
OBSERVATIONAL
Enrollment
95
Start Date
2022-03-01
Completion Date
2024-10-31
Last Updated
2024-06-25
Healthy Volunteers
No
Locations (1)
The first affiliated hospital of Zhejiang University
Hangzhou, Zhejiang, China